{
    "clinical_study": {
        "@rank": "63980", 
        "brief_summary": {
            "textblock": "RATIONALE: Laparoscopic staging may help doctors plan more effective treatment for ovarian,\n      primary fallopian tube, and primary abdominal cancers.\n\n      PURPOSE: Phase II trial to study the effectiveness of laparoscopic staging in patients with\n      ovarian, primary fallopian tube, or primary abdominal cancers who have not undergone\n      complete staging."
        }, 
        "brief_title": "Laparoscopic Staging in Patients With Ovarian, Fallopian Tube, or Other Primary Abdominal Cancers", 
        "condition": [
            "Fallopian Tube Cancer", 
            "Ovarian Cancer", 
            "Primary Peritoneal Cavity Cancer"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Ovarian Neoplasms", 
                "Peritoneal Neoplasms", 
                "Fallopian Tube Neoplasms"
            ]
        }, 
        "detailed_description": {
            "textblock": "OBJECTIVES: I. Determine the feasibility of laparoscopic staging of patients with\n      incompletely staged ovarian, primary fallopian tube, and primary peritoneal cancers. II.\n      Assess the adverse effects associated with this technique.\n\n      OUTLINE: Surgery. Laparoscopy with cytologic examination and lymph node sampling followed,\n      if feasible, by surgical resection.\n\n      PROJECTED ACCRUAL: Up to 50 patients will be accrued over approximately 2 years. If more\n      than 4 evaluable patients cannot complete surgery, the study will be closed."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "DISEASE CHARACTERISTICS: One of the following incompletely staged malignancies: Ovarian\n        cancer of any cell type Primary fallopian tube carcinoma Primary peritoneal carcinoma No\n        clinical evidence of metastases to abdominal organs, the adnexa, or retroperitoneal lymph\n        nodes on CT with contrast or at prior abdominal surgery No metastases on chest x-ray No\n        contraindications to laparoscopy, i.e.: No bowel obstruction No ileus No peritonitis No\n        excessive obesity as indicated by a Quetelet Index over 35 (weight in kg/height in sqm) No\n        diaphragmatic hernia on chest x-ray No grade 2 heart toxicity\n\n        PATIENT CHARACTERISTICS: Age: Adult Performance status: GOG 0 or 1 Hematopoietic: WBC at\n        least 3,000/mm3 Platelet count at least 100,000/mm3 Hepatic: Bilirubin no more than 1.5\n        mg/dL AST no more than 3 times normal Renal: Creatinine no more than 2.0 mg/dL Other: No\n        second malignancy except nonmelanomatous skin cancer Not pregnant\n\n        PRIOR CONCURRENT THERAPY: Biologic therapy: Not specified Chemotherapy: No prior or\n        concomitant chemotherapy Endocrine therapy: Not specified Radiotherapy: No prior or\n        concomitant abdominal or pelvic radiotherapy Surgery: No prior retroperitoneal surgery No\n        more than 10 weeks since initial abdominal surgery"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "firstreceived_date": "November 1, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00002538", 
            "org_study_id": "GOG-9302", 
            "secondary_id": "CDR0000078530"
        }, 
        "intervention": {
            "intervention_name": "laparoscopic surgery", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "stage I ovarian epithelial cancer", 
            "stage II ovarian epithelial cancer", 
            "stage III ovarian epithelial cancer", 
            "ovarian undifferentiated adenocarcinoma", 
            "ovarian mixed epithelial carcinoma", 
            "ovarian serous cystadenocarcinoma", 
            "ovarian mucinous cystadenocarcinoma", 
            "ovarian endometrioid adenocarcinoma", 
            "ovarian clear cell cystadenocarcinoma", 
            "fallopian tube cancer", 
            "primary peritoneal cavity cancer"
        ], 
        "lastchanged_date": "August 19, 2013", 
        "link": {
            "description": "Clinical trial summary from the National Cancer Institute's PDQ\u00ae database", 
            "url": "http://cancer.gov/clinicaltrials/GOG-9302"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90095-1781"
                    }, 
                    "name": "Jonsson Comprehensive Cancer Center, UCLA"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90033-0800"
                    }, 
                    "name": "USC/Norris Comprehensive Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Palo Alto", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94304"
                    }, 
                    "name": "Women's Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Washington", 
                        "country": "United States", 
                        "state": "District of Columbia", 
                        "zip": "20007"
                    }, 
                    "name": "Vincent T. Lombardi Cancer Research Center, Georgetown University"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Washington", 
                        "country": "United States", 
                        "state": "District of Columbia", 
                        "zip": "20307-5000"
                    }, 
                    "name": "Walter Reed Army Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60612"
                    }, 
                    "name": "Rush-Presbyterian-St. Luke's Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Minneapolis", 
                        "country": "United States", 
                        "state": "Minnesota", 
                        "zip": "55455"
                    }, 
                    "name": "University of Minnesota Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Durham", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27710"
                    }, 
                    "name": "Duke Comprehensive Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Winston-Salem", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27157-1082"
                    }, 
                    "name": "Comprehensive Cancer Center of Wake Forest University Baptist Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Oklahoma City", 
                        "country": "United States", 
                        "state": "Oklahoma", 
                        "zip": "73190"
                    }, 
                    "name": "University of Oklahoma College of Medicine"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Abington", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19001"
                    }, 
                    "name": "Abington Memorial Hospital"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "LAPAROSCOPIC STAGING IN PATIENTS WITH INCOMPLETELY STAGED CANCERS OF THE OVARY", 
        "overall_official": {
            "affiliation": "Women's Cancer Center - Palo Alto", 
            "last_name": "Nick M. Spirtos, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "United States: Federal Government", 
                "United States:  National Cancer Institute"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "March 2010", 
            "@type": "Actual"
        }, 
        "reference": {
            "PMID": "16260204", 
            "citation": "Spirtos NM, Eisekop SM, Boike G, Schlaerth JB, Cappellari JO. Laparoscopic staging in patients with incompletely staged cancers of the uterus, ovary, fallopian tube, and primary peritoneum: a Gynecologic Oncology Group (GOG) study. Am J Obstet Gynecol. 2005 Nov;193(5):1645-9."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00002538"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Gynecologic Oncology Group", 
        "sponsors": {
            "collaborator": {
                "agency": "National Cancer Institute (NCI)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "Gynecologic Oncology Group", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 1993", 
        "study_design": "Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }, 
    "geocoordinates": {
        "Abington Memorial Hospital": "40.12 -75.125", 
        "Comprehensive Cancer Center of Wake Forest University Baptist Medical Center": "36.1 -80.244", 
        "Duke Comprehensive Cancer Center": "35.994 -78.899", 
        "Jonsson Comprehensive Cancer Center, UCLA": "34.052 -118.244", 
        "Rush-Presbyterian-St. Luke's Medical Center": "41.878 -87.63", 
        "USC/Norris Comprehensive Cancer Center": "34.052 -118.244", 
        "University of Minnesota Cancer Center": "44.98 -93.264", 
        "University of Oklahoma College of Medicine": "35.468 -97.516", 
        "Vincent T. Lombardi Cancer Research Center, Georgetown University": "38.895 -77.036", 
        "Walter Reed Army Medical Center": "38.895 -77.036", 
        "Women's Cancer Center": "37.442 -122.143"
    }
}